Work

Abstract 4458: Clinical significance ofPIK3CAandESR1mutations in ctDNA and FFPE samples from the MONARCH 2 study of abemaciclib plus fulvestrant

Year: 2019

Type: conference-abstract

Source: Clinical Research (Excluding Clinical Trials)

DOI: 10.1158/1538-7445.sabcs18-4458

Authors: Sara M. Tolaney, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Eva-Maria Grischke, Antonio Llombart-Cussac, Hatem Soliman, Lacey M. Litchfield, Sameera Wijayawardana, Tammy Forrester, Valerie M. Jansen, George W. Sledge

Institutions: Dana-Farber Cancer Institute, Kyoto University, Universitair Ziekenhuis Leuven, Yonsei University, Yonsei Cancer Hospital, Universitäts Frauenklinik, University of Tübingen, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Hospital Arnau de Vilanova, Moffitt Cancer Center, Eli Lilly (United States), Stanford University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4253025729

Cites:

Cited by: 2

Related to: 10